GSK to invest $166m in manufacturing in Sub-Saharan Africa
GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.
Archives for March 30, 2014
InVentiv pushes into Japan again, offering consulting this time
CRO inVentiv Health subsidiary Campbell Alliance has launched its consulting business in Japan and will open an office in Tokyo nearly a year after inVentiv made its initial push into the country.
US excipients market to rise to $2B by 2018, study finds
The rapid growth of the US excipients market is going to be driven mostly by rises in polymers, gelatins and sugar alcohols, according to a new study.
Baxter to continue to grow manufacturing network in pharma spin-out
Baxter says it will spin out its pharma business to form two separate companies by 2015.
Will US track and trace law be enough to stop counterfeiters?
In light of the implementation of the Drug Quality and Security Act of 2013 in the US, which calls for the phased implementation of electronic tracking down to the package level, companies are looking at options to catch up and reduce counterfeiting at...
Hospira adds $60m to Rocky Mount's turnaround in lawsuit settlement
Hospira has agreed to pay $60m (€44m) to settle a lawsuit related to manufacturing and quality control deficiencies at its Rocky Mount facility, which is already subject to a $200m remediation programme.
CROs debate: Can surrogate endpoints speed oncology drugs to market?
As biopharma companies look to develop cancer therapies more quickly, some are turning to CROs with the hopes of using surrogate endpoints to expedite US FDA approval.